Prognostic value of plasma Epstein–Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy
Abstract Background The value of Epstein–Barr virus (EBV) DNA assay during posttreatment follow-up of the patients with nasopharyngeal carcinoma (NPC) presenting with different pretreatment plasma EBV DNA levels remains unclear. In the present study, we aimed to evaluate the prognostic value of plas...
Main Authors: | Wen-Fei Li, Yuan Zhang, Xiao-Bin Huang, Xiao-Jing Du, Ling-Long Tang, Lei Chen, Hao Peng, Rui Guo, Ying Sun, Jun Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-11-01
|
Series: | Chinese Journal of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40880-017-0256-x |
Similar Items
-
Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01) -
The role of Epstein–Barr virus in nasopharyngeal carcinoma
by: Zhi Yi Su, et al.
Published: (2023-02-01) -
EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA: VIRAL MARKERS FOR DIAGNOSTICS AND ASSESSMENT OF CLINICAL STATUS OF PATIENTS
by: V. N. Kondratova, et al.
Published: (2018-04-01) -
Nasopharyngeal Carcinoma Progression: Accumulating Genomic Instability and Persistent Epstein–Barr Virus Infection
by: Xue Liu, et al.
Published: (2022-08-01) -
Prognostic Value of Oral Epstein–Barr Virus DNA Load in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Yong-Qiao He, et al.
Published: (2022-01-01)